These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12661796)

  • 1. Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol.
    Husslein P; Quartarolo JP
    Int J Clin Pract; 2003 Mar; 57(2):121-7. PubMed ID: 12661796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
    BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour.
    Siassakos D; O'Brien K; Draycott T
    J Obstet Gynaecol; 2009 Aug; 29(6):507-11. PubMed ID: 19697198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].
    Hadar E; Mansur N; Ambar I; Hod M
    Harefuah; 2011 Jun; 150(6):502-6, 553. PubMed ID: 21800486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of atosiban and ritodrine in external cephalic version.
    Stergiotou I; Talbot F; Yoong W
    Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Fallon A; Fallon UB
    BJOG; 2007 Aug; 114(8):1043; author reply 1043-4. PubMed ID: 17635490
    [No Abstract]   [Full Text] [Related]  

  • 10. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
    Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
    Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an oxytocin receptor antagonist (atosiban) on uterine electrical activity.
    Hadar E; Melamed N; Aviram A; Raban O; Saltzer L; Hiersch L; Yogev Y
    Am J Obstet Gynecol; 2013 Oct; 209(4):384.e1-7. PubMed ID: 23727522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine.
    de Heus R; Mulder EJ; Derks JB; Kurver PH; van Wolfswinkel L; Visser GH
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):139-45. PubMed ID: 18316155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A; Hopp H; Dudenhausen J
    Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atosiban and nifedipine in the suppression of pre-term labour: a comparative study.
    Saleh SS; Al-Ramahi MQ; Al Kazaleh FA
    J Obstet Gynaecol; 2013 Jan; 33(1):43-5. PubMed ID: 23259877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tocolysis. Atosiban, an ocytcin-receptor antagonist].
    Schmitz T; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):238-45. PubMed ID: 11397999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tocolysis by first intention with atosiban].
    Gondry J
    Gynecol Obstet Fertil; 2005 Apr; 33(4):260-2. PubMed ID: 15894214
    [No Abstract]   [Full Text] [Related]  

  • 19. Preterm labour. The present and future of tocolysis.
    Giles W; Bisits A
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):857-68. PubMed ID: 17459777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of Tractocile in everyday clinical practice.
    Helmer H; Brunbauer M; Rohrmeister K
    BJOG; 2003 Apr; 110 Suppl 20():113-5. PubMed ID: 12763126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.